GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of the glucagon thing finally clicked for me and I want to write it down — 20 comments in the full submission. View in context.
399
c/retatrutide·submitted 3 months ago by u/nadia_norgaard

the glucagon thing finally clicked for me and I want to write it down

Trial Databranch of 7 comments

Thinking out loud about this: the glucagon thing finally clicked for me and I want to write it down. Read the phase 2 paper twice before ordering anything. Recommend that to anyone in this board: the error bars are the interesting part. Kept a log specifically because there is so little published. It is one person…

Read the full submission and all 20 comments →

This branch

7 comments, started 2 months ago
u/customs_seizure_sid26 points·2 months ago

The phase 2 readout ran to 48 weeks in a few hundred participants with a slow escalation. Both the size and the duration matter when people quote the headline number.

replysharereportpermalink
u/renzo_yildiz8 points·2 months ago

heart rate is the thing people report watching

replysharereportpermalink
u/crosspost_bot_no4 points·2 months ago

heart rate is the thing people report watching

Agreed, and the glucagon arm is exactly why the comparison threads do not work.

replysharereportpermalink
u/nadia_norgaardOP0 points·2 months ago

What is the source for that figure — the published paper or a summary of it?

replysharereportpermalink
u/lina_bruun1 point·2 months ago

Nothing containing this compound is approved anywhere. Research-use-only material is not approved for human use, and that is a statement of fact rather than a disclaimer.

replysharereportpermalink
u/burned_once_twice1 point·2 months ago

Glucagon receptor agonism is associated with increased energy expenditure and with hepatic effects. That is a mechanistic story with strong preclinical support and limited phase 2 human data.

replysharereportpermalink
u/deleted_my_history1 point·2 months ago

dose escalation in the trials was slow for a reason

replysharereportpermalink

← back to the whole thread

About c/retatrutide

Retatrutide: GIP/GLP-1/glucagon triple agonism, the TRIUMPH programme, and the fact that most people discussing it are handling research-grade material with no human-use approval anywhere. Dose-response, heart-rate signal, and the unusually steep phase-2 weight curves get argued about here weekly.

65kmembers
130submissions
Sep 2023created
submissions / month, last year
Sponsored

Janoshik Analytical

Independent HPLC and mass spec. The number you get is the number they found.

janoshik.com
Sponsored

GL Biochem (Shanghai)

Custom peptides and amino acids direct from the manufacturer since 1998. ISO 9001 / cGMP. Batch COA every order.

glbiochem.net
c/retatrutide rules
  1. Retatrutide is not approved anywhere for human use. Posts must not read as usage instructions.
  2. Phase 2 numbers are not maintenance numbers. Cite the trial and the dose arm.
  3. Heart-rate and dose-escalation reports need actual measurements, not impressions.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.